What to Know About Minimal Residual Disease – March 13, 2024

Webinars

LRF’s free webinars are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials, and promising innovative research. Webinars can be listened to live on the telephone or via web streaming.

What to Know About Minimal Residual Disease

DATE: Wednesday, March 13, 2024
TIME: 1:00 PM – 2:00 PM Eastern Time

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Look for Zoom as sender of confirmation and reminder emails.

Featuring

Loretta J. Nastoupil, MD
Hematologist/Oncologist
Associate Professor, Department of Lymphoma/Myeloma,
Division of Cancer Medicine
Director, Lymphoma Outcomes Database, Department of Lymphoma/Myeloma,
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center

Program Overview

  • What is Minimal Residual Disease (MRD)?
  • How is MRD different from circulating tumor DNA (ctDNA) and a liquid biopsy?
  • How is MRD detected?
  • Application of MRD in Lymphomas and CLL/SLL
  • What to ask your doctor about MRD
  • The future of MRD
  • Question and Answer Session

Ways to Register

VIRTUAL PROGRAM – This is a Zoom virtual event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Zoom will email confirmation and reminders.

Call: 800-500-9976
Email: mspellman@lymphoma.org

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, LRF recommends the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from: